The Martin Jädersten group is investigating biological and clinical aspects of acute myeloid leukemia (AML) and runs academic trials exploring novel treatment strategies. The team leader Martin ...
MDS is a type of cancer where blood-forming cells in the bone marrow become abnormal and have trouble creating new cells. To determine the best treatment approach, your doctor will need to determine ...
Candidates who wish to appear for NEET MDS 2025 must meet the required eligibility criteria before applying. They must possess a BDS degree or an equivalent qualification. Additionally, completing ...
Abstract: As wearable technology and machine learning (ML) algorithms have developed by leaps and bounds, many studies have focused on automatically monitoring Parkinson’s Disease (PD). The procedure ...
Intel's floundering foundry business hit another speed bump on Friday after executives delayed the completion of its $28 billion Ohio factory build-out until at least 2030. "As we continue to invest ...
NBEMS has announced NEET MDS 2025 will be held on April 19, 2025. The application process is set to start on February 18, 2025, and end on March 10, 2025. The information bulletin with detailed ...
Myelodysplastic syndrome (MDS) is a heterogeneous group of bone marrow stem cell disorders characterized by ineffective hematopoiesis and cytopenias, most commonly anemia. Red cell transfusion therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback